Pneumococcal conjugate vaccination in Canadian infants and children younger than five years of age: Recommendations and expected benefits.
about
Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae.The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe.Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006
P2860
Pneumococcal conjugate vaccination in Canadian infants and children younger than five years of age: Recommendations and expected benefits.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pneumococcal conjugate vaccina ...... dations and expected benefits.
@en
Pneumococcal conjugate vaccina ...... dations and expected benefits.
@nl
type
label
Pneumococcal conjugate vaccina ...... dations and expected benefits.
@en
Pneumococcal conjugate vaccina ...... dations and expected benefits.
@nl
prefLabel
Pneumococcal conjugate vaccina ...... dations and expected benefits.
@en
Pneumococcal conjugate vaccina ...... dations and expected benefits.
@nl
P2093
P2860
P356
P1476
Pneumococcal conjugate vaccina ...... dations and expected benefits.
@en
P2093
Carol A McClure
Jeff B Wilson
Jeff J Aramini
Michael W Ford
P2860
P356
10.1155/2006/835768
P407
P577
2006-01-01T00:00:00Z